What is CAD?
Computer-Aided Detection (CAD) is a sophisticated FDA-approved technology that helps radiologists identify characteristics that may be associated with various forms of cancer. By using iCAD patented algorithms to mark suspicious areas, CAD serves as a "second pair of eyes" and acts very much like a "spell checker" to identify characteristics that may warrant a "Second Look" by the radiologist.
Of the Top Cancer Hospitals in the United States, as reported by US News and World Report in 2008, iCAD's SecondLook® CAD system has been installed in fifteen (15) of these leading-edge facilities. Click the link at right to download the list.
What is CAD based on?
CAD is based on medically-applicable research in the areas of artificial intelligence, enhanced image processing, pattern recognition, mathematical formulas and statistical computations.
What are the benefits of CAD in mammography?
Clinical studies show that CAD in screening mammography can improve cancer sensitivity without a significant increase in work-up rate.**
Does the use of CAD in mammography require additional patient procedures?
No, CAD as part of the mammography screening process does not require additional procedures for patients. Simply visit a facility equipped with a SecondLook® CAD system for your next mammogram.
Will my insurance pay for mammography CAD?
Medicare and most private insurance companies in the United States consider CAD reimbursable. If you are concerned about payment for this service, we recommend contacting your insurance company directly.
** Gromet, Matthew. Comparison of Computer-Aided Detection to Double Reading of Screening Mammograms: Review of 231,221 Mammograms. AJR 2008; 190:854-859.
iCAD delivers innovative cancer detection and radiation therapy solutions and services that enable clinicians to find and treat cancers earlier and faster while improving patient outcomes. iCAD offers a comprehensive range of upgradeable computer aided detection (CAD) and workflow solutions to support rapid and accurate detection of breast and colorectal cancers.
©2017 iCAD, Inc. All rights reserved. iCAD, the iCAD and PowerLook logos are trademarks of iCAD, Inc.
Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.